The proposed project will utilize perfusion functional magnetic resonance imaging (fMRI), a functional candidate gene association approach (of dopaminergic addictions-targeted polymorphisms), and the dopamine-modulating and gamma-aminobutyric acid (GABA) B receptor agonist, baclofen, to examine the brain and behavioral responses in smokers to appetitive smoking reminders (cues that motivate continued smoking and relapse). These studies will provide a means to identify an appetitive cue-sensitive pharmacologic-responsive endophenotype. Once brain/behavioral/genetic endophenotypes can be determined prior to treatment, smoking cessation treatments can be structured to meet individual needs, which will significantly improve treatment outcome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
44
University of Pennsylvania Center for Studies of Addiction
Philadelphia, Pennsylvania, United States
Cigarettes Smoked Per Day
Cigarettes per day at Scan Day 2; Baclofen group vs. placebo group
Time frame: 3 weeks (Scan Day 1, week1- Scan Day 2, week 4)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.